Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Drug:
bexarotene
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Ultraviolet A Light Therapy With Methoxsalen (PUVA) With or Without Bexarotene in Patients With Mycosis Fungoides
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
EORTC-21011
, NCT00056056
2.
Phase II Study of Doxorubicin HCl Liposome Followed By Bexarotene in Patients With Stage IB-IV Cutaneous T-Cell Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-05098
, NCT00255801
3.
Phase II Study of Bexarotene and Sargramostim (GM-CSF) in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
JHOC-J0675
, J0675, JHOC-NA_00003076, NCT00425477
4.
BATTLE Program: Tarceva and Targretin in Patients With NSCLC
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2005-0826
, NCT00411632
5.
Phase II Study of Bexarotene and Tretinoin With Combination Chemotherapy Comprising Cisplatin or Carboplatin, Docetaxel, and Capecitabine in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
EISAI-2007-01-22
, 2007-01-22, NCT00514293
6.
Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
UPCC 04407
, UPCC 04407, NCT00615784
7.
Phase II Study of Gemcitabine Hydrochloride and Bexarotene in Patients With Progressive or Refractory Stage IB-IVA Cutaneous T-cell Non-Hodgkin Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CRUK-UCL-GEMBEX
, CRUK-UCL GemBex, EU-20841, EUDRACT 2006-000591-33, NCT00660231
8.
Study of Tarceva and Targretin in Stage I-II Lung Cancer
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
D-0453
, NCT00125372
9.
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
COMIRB# 07-0727
, NCT00718770
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute